Works by Dong, Huan


Results: 205
    1
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Cover Image, Volume 141, Issue 5.

    Published in:
    Journal of Applied Polymer Science, 2024, v. 141, n. 5, p. 1, doi. 10.1002/app.54123
    By:
    • Zhou, Di;
    • Kong, Ling‐lu;
    • Liu, Shu‐mei;
    • Yuan, Yan‐chao;
    • Ma, Yu‐guang;
    • Huang, Ming‐jun;
    • Mo, Yue‐qi;
    • Qin, Dong‐huan;
    • Zhao, Jian‐qing
    Publication type:
    Article
    30
    31
    32
    33
    34

    A novel quantum anonymous ranking protocol.

    Published in:
    Quantum Information Processing, 2021, v. 20, n. 10, p. 1, doi. 10.1007/s11128-021-03288-6
    By:
    • Li, Yue-Ran;
    • Jiang, Dong-Huan;
    • Liang, Xiang-Qian
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Efficacy and safety of eltrombopag in the treatment of immune thrombocytopenia patients with hepatitis B virus infection: A prospective, multicenter, single arm, phase II trial.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 1, p. E22, doi. 10.1002/ajh.27141
    By:
    • Chen, Yunfei;
    • Xu, Yanmei;
    • Huang, Yueting;
    • Sun, Ting;
    • Hu, Yuefen;
    • Xue, Feng;
    • Peng, Xuanwei;
    • Lai, Yinghui;
    • Zhou, Zeping;
    • Zhou, Hu;
    • Zhou, Rongfu;
    • Liu, Wei;
    • Liu, Xiaofan;
    • Dong, Huan;
    • Fu, Rongfeng;
    • Ju, Mankai;
    • Dai, Xinyue;
    • Li, Huiyuan;
    • Liu, Xiaonan;
    • Ma, Yueshen
    Publication type:
    Article
    44

    Single‐dose rituximab plus glucocorticoid versus cyclophosphamide plus glucocorticoid in patients with newly diagnosed acquired hemophilia A: A multicenter, open‐label, randomized noninferiority trial.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 1, p. 28, doi. 10.1002/ajh.27128
    By:
    • Wang, PanJing;
    • Zhou, Rongfu;
    • Xue, Feng;
    • Zhou, Hu;
    • Bai, Jie;
    • Wang, Xianghua;
    • Ma, Yueshen;
    • Song, Zhen;
    • Chen, Yunfei;
    • Liu, Xiaofan;
    • Fu, Rongfeng;
    • Sun, Ting;
    • Ju, Mankai;
    • Dai, Xinyue;
    • Dong, Huan;
    • Yang, Renchi;
    • Liu, Wei;
    • Zhang, Lei
    Publication type:
    Article
    45
    46
    47
    48
    49

    Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial.

    Published in:
    Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-01793-5
    By:
    • Chen, Yunfei;
    • Xu, Yanmei;
    • Chi, Ying;
    • Sun, Ting;
    • Gao, Yuchen;
    • Dou, Xueqing;
    • Han, Zhibo;
    • Xue, Feng;
    • Li, Huiyuan;
    • Liu, Wei;
    • Liu, Xiaofan;
    • Dong, Huan;
    • Fu, Rongfeng;
    • Ju, Mankai;
    • Dai, Xinyue;
    • Wang, Wentian;
    • Ma, Yueshen;
    • Song, Zhen;
    • Gu, Jundong;
    • Gong, Wei
    Publication type:
    Article
    50